Turning Breakthrough Discoveries
into Medicines
At 1STBIO, we strive to transform the lives of patients by relentlessly discovering and developing novel therapeutics to address areas of significant unmet need. Inspired by science and innovation, we dedicate our expertise and experience in drug development to bring forward a pioneering change.
At 1STBIO, we strive to transform the lives of patients by relentlessly discovering and developing novel therapeutics to address areas of significant unmet need. Inspired by science and innovation, we dedicate our expertise and experience in drug development to bring forward a pioneering change.
Key Focus areas
We are developing a portfolio of drug candidates in the field of Neurodegenerative Disease, Immuno-Oncology and Rare Disease as well as developing Genomic-based target discovery platform for neurodegenerative target and biomarker discovery.
Meet the Team
1STBIO was founded by experienced veterans in the life science industry with an aim to assemble a team with scientific, clinical, and business expertise. Since its inception, seasoned professionals in their respective fields have joined together with an unwavering focus on discovering and developing therapeutics to improve patients’ lives.
Latest News
1ST Biotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate FB849 in Combination With KEYTRUDA® (pembrolizumab)
September 20, 2023
1STBIO 신규 사명 / CI 공모전 결과 공고
August 18, 2023
신주 발행 공고
June 29, 2023
합병종료보고 공고
June 2, 2023
Where We’re Located
1ST Biotherapeutics, Inc.
338, Gwanggyojungang-ro, Gwanggyowoominewv, Suji-gu, Yongin-si, Gyeonggi-do, South Korea
Suite A813, A1027, C603, C806, C807, C808, C809